These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


270 related items for PubMed ID: 16622218

  • 21. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K, Mann BJ, Qin A, Barry EM, Ernst RK, Vogel SN.
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
    [Abstract] [Full Text] [Related]

  • 22. Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge.
    Cole LE, Yang Y, Elkins KL, Fernandez ET, Qureshi N, Shlomchik MJ, Herzenberg LA, Herzenberg LA, Vogel SN.
    Proc Natl Acad Sci U S A; 2009 Mar 17; 106(11):4343-8. PubMed ID: 19251656
    [Abstract] [Full Text] [Related]

  • 23. Toll-like receptor 2 controls the gamma interferon response to Francisella tularensis by mouse liver lymphocytes.
    Hong KJ, Wickstrum JR, Yeh HW, Parmely MJ.
    Infect Immun; 2007 Nov 17; 75(11):5338-45. PubMed ID: 17785474
    [Abstract] [Full Text] [Related]

  • 24. Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection.
    Gentry M, Taormina J, Pyles RB, Yeager L, Kirtley M, Popov VL, Klimpel G, Eaves-Pyles T.
    Infect Immun; 2007 Aug 17; 75(8):3969-78. PubMed ID: 17502386
    [Abstract] [Full Text] [Related]

  • 25. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).
    De Pascalis R, Chou AY, Ryden P, Kennett NJ, Sjöstedt A, Elkins KL.
    mBio; 2014 Apr 08; 5(2):e00936. PubMed ID: 24713322
    [Abstract] [Full Text] [Related]

  • 26. Francisella tularensis LVS-induced Interleukin-12 p40 cytokine production mediates dendritic cell migration through IL-12 Receptor β1.
    Slight SR, Lin Y, Messmer M, Khader SA.
    Cytokine; 2011 Sep 08; 55(3):372-9. PubMed ID: 21669537
    [Abstract] [Full Text] [Related]

  • 27. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria.
    Ben Nasr A, Haithcoat J, Masterson JE, Gunn JS, Eaves-Pyles T, Klimpel GR.
    J Leukoc Biol; 2006 Oct 08; 80(4):774-86. PubMed ID: 16857732
    [Abstract] [Full Text] [Related]

  • 28. A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
    Jia Q, Bowen R, Sahakian J, Dillon BJ, Horwitz MA.
    Infect Immun; 2013 May 08; 81(5):1550-61. PubMed ID: 23439306
    [Abstract] [Full Text] [Related]

  • 29. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R, Harris G, Conlan JW, Chen W.
    Vaccine; 2007 May 10; 25(19):3781-91. PubMed ID: 17346863
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Species-specific recognition of Aspergillus fumigatus by Toll-like receptor 1 and Toll-like receptor 6.
    Rubino I, Coste A, Le Roy D, Roger T, Jaton K, Boeckh M, Monod M, Latgé JP, Calandra T, Bochud PY.
    J Infect Dis; 2012 Mar 15; 205(6):944-54. PubMed ID: 22315281
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A conserved and immunodominant lipoprotein of Francisella tularensis is proinflammatory but not essential for virulence.
    Forestal CA, Gil H, Monfett M, Noah CE, Platz GJ, Thanassi DG, Benach JL, Furie MB.
    Microb Pathog; 2008 Jun 15; 44(6):512-23. PubMed ID: 18304778
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Infection with Francisella tularensis LVS clpB leads to an altered yet protective immune response.
    Barrigan LM, Tuladhar S, Brunton JC, Woolard MD, Chen CJ, Saini D, Frothingham R, Sempowski GD, Kawula TH, Frelinger JA.
    Infect Immun; 2013 Jun 15; 81(6):2028-42. PubMed ID: 23529616
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.